Literature DB >> 2440877

Crystallization of the lectin IV of Griffonia simplicifolia and its complexes with the Lewis b and Y human blood group determinants.

M Vandonselaar, L T Delbaere, U Spohr, R U Lemieux.   

Abstract

Single crystals of the lectin IV from Griffonia simplicifolia have been grown in the tetragonal crystal system. The space group is P4(2)2(1)2 with a = 78.95(5) A and c = 89.01(2) A, and there is one subunit of the dimeric glycoprotein in the crystallographic asymmetric unit. The crystals diffract to at least 2.5 A d spacings and are stable in the x-ray beam for 3 weeks. Crystals of the complex with the Lewis b (Leb) and Y human blood group determinants as the methyl glycosides, alpha-L-Fuc(1----2)beta-D-Gal(1----3)[alpha-L-Fuc(1----4)]beta-D-GlcNAc-OMe (where Fuc is fucose and -OMe is methoxy) and alpha-L-Fuc(1----2)beta-D-Gal(1----4)[alpha-L-Fuc(1----3)]-beta-D-GlcNAc- OMe, respectively, have also been grown and found to be isomorphous with the native lectin. Crystals have also been obtained with several derivatives of the Lewis b-OMe tetrasaccharide including that which has the 6-hydroxyl of the beta-D-GlcNAc unit replaced by iodine. In the latter case, the presence of the iodine atoms was established.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440877

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Molecular-mass heterogeneity of Griffonia simplicifolia lectin IV subunits. Differences in the oligosaccharide moieties in the N-terminal region.

Authors:  P V Nikrad; J R Pearlstone; M R Carpenter; R U Lemieux; L B Smillie
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

2.  Recognition of the blood group H type 2 trisaccharide epitope by 28 monoclonal antibodies and three lectins.

Authors:  R Mollicone; A Cailleau; A Imberty; P Gane; S Perez; R Oriol
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

3.  Therapeutic targeting of Lewis(y) and Lewis(b) with a novel monoclonal antibody 692/29.

Authors:  Philip Noble; Ian Spendlove; Stephen Harding; Tina Parsons; Lindy G Durrant
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.